Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Cell

• Publication date

  2017-08-14

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1016/j.ccell.2017.06.010PMID 28756993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer

  2017cited by this paper
• Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy

  2016cited by this paper
• Characterizing genomic alterations in cancer by complementary functional associations

  2016cited by this paper
• Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

  2016cited by this paper
• A Landscape of Pharmacogenomic Interactions in Cancer

  2016influential reference
• ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice

  2016cited by this paper
• Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

  2016cited by this paper
• Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

  2016cited by this paper
• Oncotator: Cancer Variant Annotation Tool

  2015cited by this paper
• Cancer type-dependent genetic interactions between cancer driver alterations indicate plasticity of epistasis across cell types

  2015cited by this paper
• Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

  2015cited by this paper
• Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer

  2015cited by this paper
• The Molecular Taxonomy of Primary Prostate Cancer.

  2015cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma

  2015cited by this paper
• Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

  2015cited by this paper
• Genomic Classification of Cutaneous Melanoma.

  2015cited by this paper
• Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

  2015cited by this paper
• Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

  2015cited by this paper
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

  2015cited by this paper
• Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

  2015cited by this paper
• Comprehensive genomic characterization of head and neck squamous cell carcinomas

  2015cited by this paper
• CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer

  2014cited by this paper
• Discovery and saturation analysis of cancer genes across 21 tumor types

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• The somatic genomic landscape of chromophobe renal cell carcinoma.

  2014cited by this paper
• RNF43 is frequently mutated in colorectal and endometrial cancers

  2014cited by this paper
• Comprehensive molecular characterization of gastric adenocarcinoma

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

  2014influential reference
• Integrated genomic characterization of papillary thyroid carcinoma.

  2014cited by this paper
• Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

  2014cited by this paper
• Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

  2014cited by this paper
• Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication

  2014cited by this paper
• An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer

  2014cited by this paper
• Emerging landscape of oncogenic signatures across human cancers

  2013cited by this paper
• Pan-cancer patterns of somatic copy-number alteration

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• Punctuated evolution of prostate cancer genomes.

  2013cited by this paper
• Integrated genomic characterization of endometrial carcinoma

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• The Cancer Genome Atlas Pan-Cancer analysis project

  2013cited by this paper
• The causes and consequences of genetic heterogeneity in cancer evolution

  2013cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Protein structure prediction from sequence variation

  2012cited by this paper
• Mutual exclusivity analysis identifies oncogenic network modules.

  2012cited by this paper
• Chromothripsis and cancer: causes and consequences of chromosome shattering

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Clonal evolution in cancer

  2012cited by this paper
• De Novo Discovery of Mutated Driver Pathways in Cancer

  2011cited by this paper
• Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

  2011cited by this paper
• Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

  2011cited by this paper
• Clonal evolution in cancer

  2010cited by this paper
• Patient-oriented gene set analysis for cancer mutation data

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

  2010cited by this paper
• Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

  2009cited by this paper
• Accumulation of driver and passenger mutations during tumor progression

  2009cited by this paper
• Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction

  2008cited by this paper
• KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

  2007cited by this paper
• High-throughput oncogene mutation profiling in human cancer

  2007cited by this paper
• Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo

  2006influential reference
• A Mathematical Theory of Communication

  2006cited by this paper
• A mouse model for cyclin E-dependent genetic instability and tumorigenesis.

  2005cited by this paper
• p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.

  2002cited by this paper
• Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status

  2002cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• Comparison of the predicted and observed secondary structure of T4 phage lysozyme.

  1975cited by this paper

• The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy.

  2026cites this paper
• Tobacco smoke alters the trajectory of lung adenocarcinoma evolution via effects on somatic selection and epistasis

  2025cites this paper
• Frequent Whole-Genome Duplication Events Drive the Genomic Evolution of Triple-Negative Breast Cancer During Neoadjuvant Chemotherapy

  2025influential citation
• Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer

  2025cites this paper
• Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis.

  2025cites this paper
• Comprehensive molecular characterization of Rho GTPases and their regulators across human cancers

  2025cites this paper
• Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns

  2025cites this paper
• Radiomics-Enhanced Multi-Modal Deep Learning Pipelines for Stratified Cancer Prognosis Using Integrated Imaging Genomics and Clinical Data

  2025cites this paper
• Evolutionary Transcriptomics of Cancer Development

  2025cites this paper
• Mucin-producing urothelial-type adenocarcinoma of the prostate with a gene mutation characteristic of intestinal adenocarcinoma: case report and literature review

  2025cites this paper
• The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target

  2025influential citation
• The three YTHDF paralogs and VIRMA are the major tumor drivers among the m6A core genes in a pan-cancer analysis

  2024cites this paper
• Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer.

  2024cites this paper
• The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes

  2024cites this paper
• Identifying cooperating cancer driver genes in individual patients through hypergraph random walk

  2024cites this paper
• Evolutionary dependency of cancer mutations in gene pairs inferred by nonsynonymous-synonymous mutation ratios

  2024influential citation
• In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications

  2024influential citation
• Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).

  2024cites this paper
• Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancer

  2024cites this paper
• Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas

  2024cites this paper
• TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes

  2024cites this paper
• Co-occurring Mutations in Different Genes Can Fuel Oncogenic Signaling and Serve as Metastatic Tumor Markers

  2024cites this paper
• Synergistic epistasis among cancer drivers can rescue early tumors from the accumulation of deleterious passengers

  2024cites this paper
• Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.

  2024cites this paper
• Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases.

  2024cites this paper
• Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer

  2024cites this paper
• Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC.

  2023cites this paper
• Molecular Profiling Provides Clinical Insights into Targeted and Immunotherapies as well as Colorectal Cancer Prognosis.

  2023cites this paper
• The evolution of lung cancer and impact of subclonal selection in TRACERx

  2023cites this paper
• Genetic differences between smokers and never-smokers with lung cancer

  2023cites this paper
• Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

  2023cites this paper
• Cancer Evolution: A Multifaceted Affair

  2023cites this paper
• Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities

  2023cites this paper
• Oncogenic pathways refine a new perspective on the classification of hepatocellular carcinoma.

  2023cites this paper
• STK11/LKB1 Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/IFN-I/CD8+ T cell Dysfunction in Non-Small Cell Lung Cancer.

  2023cites this paper
• The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer

  2022cites this paper
• Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival.

  2022cites this paper
• Bayesian networks elucidate complex genomic landscapes in cancer

  2022cites this paper
• Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer

  2022cites this paper
• SuperDendrix algorithm integrates genetic dependencies and genomic alterations across pathways and cancer types

  2022influential citation
• Pervasive conditional selection of driver mutations and modular epistasis networks in cancer

  2022cites this paper
• Computational methods and translational applications for targeted next‐generation sequencing platforms

  2022cites this paper
• Checking for non-Euclidean latent geometry of biological networks

  2022cites this paper
• The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset

  2022cites this paper
• Epistasis and evolutionary dependencies in human cancers.

  2022cites this paper
• Enhanced Deep Learning Model for Personalized Cancer Treatment

  2022cites this paper
• ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer

  2022influential citation
• Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers

  2022cites this paper
• Editorial: Cancer evolution: From biological insights to therapeutic opportunities

  2022cites this paper
• Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities

  2022cites this paper
• E NUMERATING SETS OF GENOMIC ALTERATIONS CHARACTERIZING A USER - DEFINED SUBGROUP

  2021cites this paper
• Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression.

  2021cites this paper
• Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma

  2021cites this paper
• Synthetic Lethality in Cancer Therapeutics: The Next Generation.

  2021cites this paper
• Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.

  2021cites this paper
• A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers

  2021cites this paper
• A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies.

  2021cites this paper
• Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations

  2021cites this paper
• A systematic analysis of genetic interactions and their underlying biology in childhood cancer

  2021cites this paper
• Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

  2021cites this paper
• Genomic and experimental evidence that ALKATI does not predict single agent sensitivity to ALK inhibitors

  2021cites this paper
• Molecular characterization of metabolic subtypes of gastric cancer based on metabolism-related lncRNA

  2021cites this paper
• Genomic and experimental evidence that alternate transcription initiation of the Anaplastic Lymphoma Kinase (ALK) kinase domain does not predict single agent sensitivity to ALK inhibitors

  2021cites this paper
• Discovering functional evolutionary dependencies in human cancers

  2020cites this paper
• Genotyping data of routinely processed matched primary/metastatic tumor samples

  2020cites this paper
• A comprehensive map of genetic interactions in childhood cancer reveals multiple underlying biological mechanisms

  2020cites this paper
• MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations

  2020cites this paper
• Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation

  2020cites this paper
• Evolutionary dependencies show paths to cancer development

  2020cites this paper
• Identification of cancer drivers, conserved alteration patterns and evolutionary trajectories in tumors

  2020cites this paper
• Discovering functional evolutionary dependencies in human cancers

  2020cites this paper
• Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

  2020cites this paper
• Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

  2020cites this paper
• Identifying modules of cooperating cancer drivers

  2020influential citation
• Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma

  2020cites this paper
• A genomic and epigenomic atlas of prostate cancer in Asian populations

  2020cites this paper
• MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.

  2020cites this paper
• Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma

  2019cites this paper
• Genome Sequencing during a Patient's Journey through Cancer.

  2019cites this paper
• DriverDBv3: a multi-omics database for cancer driver gene research

  2019cites this paper
• Dynamic Emergence of Observed and Hidden Intra-tumor Heterogeneity

  2019cites this paper
• Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy

  2019cites this paper
• Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

  2019cites this paper
• Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma

  2019cites this paper
• Discovering Pathway and Cell Type Signatures in Transcriptomic Compendia with Machine Learning

  2019cites this paper
• Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

  2019cites this paper
• The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.

  2019cites this paper
• Identifying Epistasis in Cancer Genomes: A Delicate Affair.

  2019cites this paper
• Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer

  2019cites this paper
• Context-dependent selection as the keystone in the somatic evolution of cancer

  2019cites this paper
• Relapsed and De Novo Metastatic HER2‐positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

  2019cites this paper
• Pairwise tests for conditional selection use evolutionary logic to predict intrinsic drug resistance in ALK alterations

  2019cites this paper
• Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance

  2018cites this paper
• Evolutionary in Silico Cancer Simulator , Cancer Research 1 esiCancer : Evolutionary in Silico Cancer Simulator

  2018cites this paper
• Predicting drug response of tumors from integrated genomic profiles by deep neural networks

  2018cites this paper
• Data-Driven Methods for Advancing Precision Oncology

  2018cites this paper
• Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice

  2018cites this paper
• Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

  2018cites this paper
• Oncogenic Signaling Pathways in The Cancer Genome Atlas.

  2018influential citation
• PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

  2018cites this paper